TV Jr, Hobbins JC Treatment of fetal supraventricular tachyarrhythmias J Clin Ultrasound 1985;13(4):265–273 51 Lopes LM, Cha SC, Scanavacca MI, Tuma-Calil VM, Zugaib M Fetal idiopathic ventricular tachycardia with nonimmune hydrops: benign course Pediatr Cardiol 1996;17(3):192–193 52 Sherer DM, Sadovksy E, Menashe M, Mordel N, Rein AJ Fetal ventricular tachycardia associated with nonimmunologic hydrops fetalis A case report J Reprod Med 1990;35(3):292–294 53 Cuneo BF, Strasburger JF Management strategy for fetal tachycardia Obstet Gynecol 2000;96(4):575–581 54 Cuneo BF, Ovadia M, Strasburger JF, et al Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome Am J Cardiol 2003;91(11):1395–1398 55 Simpson JM, Maxwell D, Rosenthal E, Gill H Fetal ventricular tachycardia secondary to long QT syndrome treated with maternal intravenous magnesium: case report and review of the literature Ultrasound Obstet Gynecol 2009;34(4):475–480 56 Horigome H, Nagashima M, Sumitomo N, et al Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan Circ Arrhythm Electrophysiol 2010;3(1):10–17 57 Cuneo BF, Etheridge SP, Horigome H, et al Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome Circ Arrhythm Electrophysiol 2013;6(5):946–951 58 Schleich JM, Bernard Du Haut Cilly F, Laurent MC Almange C Early prenatal management of a fetal ventricular tachycardia treated in utero by amiodarone with long term follow-up Prenat Diagn 2000;20(6):449–452 59 Badhwar N, Scheinman MM Idiopathic ventricular tachycardia: diagnosis and management Curr Probl Cardiol 2007;32(1):7– 43 60 Cuneo BF, Strasburger JF, Niksch A, Ovadia M, Wakai RT An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac disease J Matern Fetal Neonatal Med 2009;22(3):233–238 61 Zimmerman D Fetal and neonatal hyperthyroidism Thyroid 1999;9(7):727–733 62 Nachum Z, Rakover Y, Weiner E, Shalev E Graves’ disease in pregnancy: prospective evaluation of a selective invasive treatment protocol Am J Obstet Gynecol 2003;189(1):159–165 63 Alexander EK, Pearce EN, Brent GA, et al 2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum Thyroid 2017;27(3):315–389 64 Andersen SL, Olsen J, Wu CS, Laurberg P Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study J Clin Endocrinol Metab 2013;98(11):4373–4381 65 Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E The importance of the level of maternal anti-ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants J Am Coll Cardiol 2010;55(24):2778–2784 66 Kan N, Silverman ED, Kingdom J, et al Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy Prenat Diagn 2017;37(4):375–382 67 Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP Immunohistologic evidence supports apoptosis, IgG deposition, and novel